|
Volumn 14, Issue 5, 2000, Pages 429-431
|
The use of thalidomide in the management of severe sweating in patients with advanced malignany: Trial report
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CAPTOPRIL;
CISAPRIDE;
CYPROTERONE;
DIAZEPAM;
DILTIAZEM;
DOXEPIN;
ENALAPRIL MALEATE;
FAMOTIDINE;
GOSERELIN;
ISOSORBIDE 5 NITRATE;
METOCLOPRAMIDE;
MORPHINE;
MORPHINE SULFATE;
NITRAZEPAM;
OMEPRAZOLE;
PARACETAMOL;
PRAZOSIN;
PROCHLORPERAZINE MALEATE;
RANITIDINE;
THALIDOMIDE;
TUMOR NECROSIS FACTOR ALPHA;
VERAPAMIL;
ADULT;
AGED;
ARTICLE;
CANCER PALLIATIVE THERAPY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CYTOKINE RELEASE;
DISEASE ASSOCIATION;
DISEASE SEVERITY;
DROWSINESS;
DRUG EFFECT;
DRUG EFFICACY;
FEMALE;
FEVER;
HUMAN;
HYPERHIDROSIS;
KIDNEY CARCINOMA;
LIVER METASTASIS;
LUNG METASTASIS;
MALE;
MELANOMA;
MESOTHELIOMA;
NAUSEA;
NONHODGKIN LYMPHOMA;
PNEUMONIA;
PROSTATE CANCER;
RECTUM CANCER;
TERATOGENICITY;
|
EID: 0033823975
PISSN: 02692163
EISSN: None
Source Type: Journal
DOI: 10.1191/026921600701536110 Document Type: Article |
Times cited : (18)
|
References (4)
|